AP2841A - Probiotic strain and antimicrobial peptide derivedtherefrom - Google Patents
Probiotic strain and antimicrobial peptide derivedtherefromInfo
- Publication number
- AP2841A AP2841A AP2008004626A AP2008004626A AP2841A AP 2841 A AP2841 A AP 2841A AP 2008004626 A AP2008004626 A AP 2008004626A AP 2008004626 A AP2008004626 A AP 2008004626A AP 2841 A AP2841 A AP 2841A
- Authority
- AP
- ARIPO
- Prior art keywords
- derivedtherefrom
- antimicrobial peptide
- probiotic strain
- probiotic
- strain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200604035A ZA200604035B (en) | 2005-05-31 | 2006-05-28 | Improved grenade launcher |
PCT/IB2007/051982 WO2007138538A2 (en) | 2006-05-28 | 2007-05-25 | Probiotic strain and antimicrobial peptide derived therefrom |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2008004626A0 AP2008004626A0 (en) | 2008-10-31 |
AP2841A true AP2841A (en) | 2014-02-28 |
Family
ID=38779065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2008004626A AP2841A (en) | 2006-05-28 | 2007-05-25 | Probiotic strain and antimicrobial peptide derivedtherefrom |
Country Status (13)
Country | Link |
---|---|
US (2) | US7951385B2 (xx) |
EP (1) | EP2021457B1 (xx) |
JP (1) | JP2009538614A (xx) |
KR (1) | KR101521123B1 (xx) |
CN (1) | CN101454440B (xx) |
AP (1) | AP2841A (xx) |
AU (1) | AU2007266675B2 (xx) |
CA (1) | CA2647161A1 (xx) |
EA (1) | EA017558B1 (xx) |
IL (2) | IL195520A0 (xx) |
NO (1) | NO20084577L (xx) |
NZ (1) | NZ571619A (xx) |
WO (1) | WO2007138538A2 (xx) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2647161A1 (en) * | 2006-05-28 | 2007-12-06 | Cipla Medpro Research And Development (Pty) Ltd | Probiotic strain and antimicrobial peptide derived therefrom |
US8357519B2 (en) * | 2008-11-19 | 2013-01-22 | The Ohio State University | Methods and processes for producing esters |
WO2011045764A1 (en) * | 2009-10-15 | 2011-04-21 | Cipla Medpro Research And Development (Pty) Ltd | A product for delivering antimicrobially active substances to an infected site |
WO2012060312A1 (ja) * | 2010-11-05 | 2012-05-10 | 国立大学法人広島大学 | 籾殻または玄米から単離された植物乳酸菌およびその利用 |
US20120294924A1 (en) * | 2011-04-29 | 2012-11-22 | Thomas Tice | Peptide-Lipid Conjugates And Uses Thereof |
RU2532227C1 (ru) * | 2013-10-23 | 2014-10-27 | Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) | Штамм enterоcoccus mundtii, продуцирующий субстанцию пептидной природы с антилистериозной активностью |
RU2599430C1 (ru) * | 2015-07-23 | 2016-10-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | ШТАММ ЛАКТОБАКТЕРИЙ Enterococcus mundtii - ПРОДУЦЕНТ МОЛОЧНОЙ КИСЛОТЫ И АНТИБИОТИЧЕСКИХ ВЕЩЕСТВ |
US9944960B2 (en) * | 2015-11-17 | 2018-04-17 | Premier Research Labs, Lp | Process for microbial production of dihydrolipoic acid and extraction of dihydrolipoic acid with edible oils |
CN105385636A (zh) * | 2015-12-07 | 2016-03-09 | 江南大学 | 一株产细菌素的肠膜明串珠菌及其应用 |
JP2019510036A (ja) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | プロバイオティクス/プレバイオティクス有効成分を含む清浄剤組成物 |
AU2017240068B2 (en) | 2016-03-31 | 2022-12-15 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
KR101722255B1 (ko) * | 2016-04-22 | 2017-04-03 | 주식회사 폴인브레드 | 쌀과 쌀누룩을 이용한 자연발효종 제조방법 |
EP3544575A1 (en) | 2016-11-23 | 2019-10-02 | GOJO Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
MX2020003100A (es) * | 2017-09-19 | 2020-08-20 | Advaxis Inc | Composiciones y metodos para la liofilizacion de bacterias o cepas de listeria. |
CA3088601A1 (en) * | 2018-01-31 | 2019-08-08 | Nutri Co., Ltd. | Prophylactic and/or therapeutic agents for streptococcus pneumoniae infection |
KR102076089B1 (ko) | 2018-10-02 | 2020-02-11 | 서울대학교 산학협력단 | 니신 z 생산능이 우수한 락토코커스 락티스 서브스페시스 락티스 ldtm 6804 신균주(kctc 13564bp) |
CN109456911B (zh) * | 2018-10-10 | 2019-10-18 | 南京林业大学 | 一株蒙氏肠球菌HcM7及其应用 |
CN110846260B (zh) * | 2019-12-18 | 2021-03-02 | 江南大学 | 一株降低生物胺的肉葡萄球菌及其应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1084969A (ja) | 1996-09-19 | 1998-04-07 | Chemo Sero Therapeut Res Inst | ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法 |
US7655775B2 (en) * | 1997-09-05 | 2010-02-02 | Canbiocin, Inc. | Expression vectors for treating bacterial infections |
AU7898700A (en) | 1999-10-22 | 2001-05-08 | Shanghai Bio Road Gene Development Ltd. | A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide |
GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
DE10105347A1 (de) * | 2001-02-05 | 2002-08-22 | Nutrinova Gmbh | Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht |
GB0125535D0 (en) | 2001-10-24 | 2001-12-12 | Microbiological Res Authority | Mycobacterial genes down-regulated during latency |
US6878373B2 (en) | 2001-12-03 | 2005-04-12 | Micropure Technologies, Inc. | Probiotic composition containing Bacillus cereus RRRL B-30535 |
JP4111489B2 (ja) * | 2002-05-23 | 2008-07-02 | プリマハム株式会社 | 新規バクテリオシン |
WO2004005492A2 (en) * | 2002-07-03 | 2004-01-15 | Galina Gennadievna Alekhina | Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof |
EP1384483A1 (en) | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
ITBO20020564A1 (it) | 2002-09-06 | 2004-03-07 | Alfa Wassermann Spa | Bifidobatteri e preparazioni che li contengono. |
CA2647161A1 (en) * | 2006-05-28 | 2007-12-06 | Cipla Medpro Research And Development (Pty) Ltd | Probiotic strain and antimicrobial peptide derived therefrom |
-
2007
- 2007-05-25 CA CA002647161A patent/CA2647161A1/en not_active Abandoned
- 2007-05-25 CN CN2007800198580A patent/CN101454440B/zh not_active Expired - Fee Related
- 2007-05-25 WO PCT/IB2007/051982 patent/WO2007138538A2/en active Application Filing
- 2007-05-25 AU AU2007266675A patent/AU2007266675B2/en not_active Ceased
- 2007-05-25 US US12/302,067 patent/US7951385B2/en active Active
- 2007-05-25 JP JP2009512739A patent/JP2009538614A/ja active Pending
- 2007-05-25 EA EA200802409A patent/EA017558B1/ru not_active IP Right Cessation
- 2007-05-25 KR KR1020087031307A patent/KR101521123B1/ko not_active IP Right Cessation
- 2007-05-25 NZ NZ571619A patent/NZ571619A/en not_active IP Right Cessation
- 2007-05-25 AP AP2008004626A patent/AP2841A/xx active
- 2007-05-25 EP EP07736018.8A patent/EP2021457B1/en active Active
-
2008
- 2008-11-03 NO NO20084577A patent/NO20084577L/no not_active Application Discontinuation
- 2008-11-26 IL IL195520A patent/IL195520A0/en unknown
-
2011
- 2011-04-26 US US13/094,155 patent/US8444998B2/en not_active Expired - Fee Related
-
2017
- 2017-02-16 IL IL250634A patent/IL250634A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA200802409A1 (ru) | 2009-10-30 |
CN101454440B (zh) | 2013-05-29 |
CN101454440A (zh) | 2009-06-10 |
IL195520A0 (en) | 2011-08-01 |
NZ571619A (en) | 2011-10-28 |
US20110268703A1 (en) | 2011-11-03 |
AP2008004626A0 (en) | 2008-10-31 |
CA2647161A1 (en) | 2007-12-06 |
EA017558B1 (ru) | 2013-01-30 |
NO20084577L (no) | 2008-12-19 |
IL250634A0 (en) | 2017-03-30 |
US7951385B2 (en) | 2011-05-31 |
WO2007138538A2 (en) | 2007-12-06 |
EP2021457A2 (en) | 2009-02-11 |
WO2007138538A3 (en) | 2008-04-17 |
KR101521123B1 (ko) | 2015-05-19 |
JP2009538614A (ja) | 2009-11-12 |
KR20090023626A (ko) | 2009-03-05 |
US8444998B2 (en) | 2013-05-21 |
AU2007266675A1 (en) | 2007-12-06 |
AU2007266675B2 (en) | 2012-09-06 |
EP2021457B1 (en) | 2015-02-11 |
US20090297482A1 (en) | 2009-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL250634A0 (en) | Probiotic sequence and generation of an antimicrobial peptide from it | |
EP2142572A4 (en) | TGFP CAP PEPTIDE AND APPLICATIONS THEREOF | |
IL199041A (en) | We nanoparticle peptides and their uses | |
ZA200810323B (en) | Fkbp-l and uses thereof | |
EP1976864A4 (en) | NEW PEPTIDE AND ITS USE | |
SI2064327T1 (sl) | DBAIT in njegova uporaba | |
SI2178549T1 (sl) | Protimikrobni peptid in pripravki iz njega | |
HK1145506A1 (en) | Peptides and their use | |
GB0712670D0 (en) | Isolated peptides and uses thereof | |
IL201018A0 (en) | Novel asparaginases and uses thereof | |
IL194751A0 (en) | Drugs and uses | |
HK1133552A1 (en) | Carboranylporphyrins and uses thereof | |
HRP20150195T1 (xx) | Antibakterijski peptidi | |
IL195525A0 (en) | Replikin peptides and uses thereof | |
GB0702022D0 (en) | Peptides and their use | |
GB0604187D0 (en) | Peptide and uses thereof | |
IL193469A0 (en) | Novel lipases and uses thereof | |
PL2222692T3 (pl) | Syntetyczny peptyd wiążący się z ludzkim CD154 i jego zastosowania | |
PL2032708T3 (pl) | Rekombinowane nowirabdowirusy i ich zastosowania | |
IL192800A0 (en) | Fgf2-binding peptides and uses thereof | |
ZA200808152B (en) | Probiotic strain and antimicrobial peptide derived therefrom | |
GB0612873D0 (en) | Isolated peptides and uses thereof | |
PL378824A1 (pl) | Peptyd i jego zastosowanie | |
GB0710813D0 (en) | Peptides and uses thereof | |
GB0711596D0 (en) | Mechanical connection and valve comprising the same |